Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard C. Becker

Showing results (81-90 of 329) with videos related to

Pageof 33
Sort By:
American Heart Journal|March 3, 2015
The periprocedural management of novel oral anticoagulants in patients with nonvalvular atrial fibrillation: rationale and a summary of the available evidence from phase 3 clinical trialsArun Krishnamoorthy, Matthew W Sherwood, Renato D Lopes, et al.
Thrombosis and Haemostasis|December 8, 2004
Development of DX-9065a, a novel direct factor Xa antagonist, in cardiovascular diseaseRichard C Becker, John Alexander, Christopher K Dyke, et al.
The Annals of Thoracic Surgery|March 20, 2002
Intramural hematoma of the thoracic aorta in a woman with neurofibromatosisOmar A Ali, Nsidinanya Okike, Robert G Hogan, et al.
Coronary Artery Disease|April 14, 2018
Inflammation and coronary artery disease: from pathophysiology to Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS)Mahboob Ali, Sameh Girgis, Atif Hassan, et al.
Journal of Thrombosis and Thrombolysis|April 21, 2019
Acquired Von Willebrand Syndrome (AVWS) in cardiovascular disease: a state of the art review for cliniciansRadha Mehta, Muhammad Athar, Sameh Girgis, et al.
Journal of Thrombosis and Thrombolysis|October 12, 2012
The effect of surface contact activation and temperature on plasma coagulation with an RNA aptamer directed against factor IXaAnandi Krishnan, Erwin A Vogler, Bruce A Sullenger, et al.
Journal of Thrombosis and Thrombolysis|August 23, 2024
The COVID-19 thrombus: distinguishing pathological, mechanistic, and phenotypic features and managementRichard C Becker, Udaya S Tantry, Muhammad Khan, et al.
Journal of Thrombosis and Thrombolysis|November 2, 2007
Determining the efficacy of antiplatelet therapies for the individual: lessons from clinical trialsSteven R Steinhubl, David J Schneider, Peter B Berger, et al.
Pharmacotherapy|February 26, 2008
Clopidogrel-associated bleeding and related complications in patients undergoing coronary artery bypass graftingA Simon Pickard, Richard C Becker, Glen T Schumock, et al.
Nucleic Acid Therapeutics|February 17, 2016
Translation and Clinical Development of Antithrombotic AptamersShahid M Nimjee, Thomas J Povsic, Bruce A Sullenger, et al.
Pageof 33

Showing results (81-90 of 329) with videos related to

Sort By:
Pageof 33
American Heart Journal|March 3, 2015
The periprocedural management of novel oral anticoagulants in patients with nonvalvular atrial fibrillation: rationale and a summary of the available evidence from phase 3 clinical trialsArun Krishnamoorthy, Matthew W Sherwood, Renato D Lopes, et al.
Thrombosis and Haemostasis|December 8, 2004
Development of DX-9065a, a novel direct factor Xa antagonist, in cardiovascular diseaseRichard C Becker, John Alexander, Christopher K Dyke, et al.
The Annals of Thoracic Surgery|March 20, 2002
Intramural hematoma of the thoracic aorta in a woman with neurofibromatosisOmar A Ali, Nsidinanya Okike, Robert G Hogan, et al.
Coronary Artery Disease|April 14, 2018
Inflammation and coronary artery disease: from pathophysiology to Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS)Mahboob Ali, Sameh Girgis, Atif Hassan, et al.
Journal of Thrombosis and Thrombolysis|April 21, 2019
Acquired Von Willebrand Syndrome (AVWS) in cardiovascular disease: a state of the art review for cliniciansRadha Mehta, Muhammad Athar, Sameh Girgis, et al.
Journal of Thrombosis and Thrombolysis|October 12, 2012
The effect of surface contact activation and temperature on plasma coagulation with an RNA aptamer directed against factor IXaAnandi Krishnan, Erwin A Vogler, Bruce A Sullenger, et al.
Journal of Thrombosis and Thrombolysis|August 23, 2024
The COVID-19 thrombus: distinguishing pathological, mechanistic, and phenotypic features and managementRichard C Becker, Udaya S Tantry, Muhammad Khan, et al.
Journal of Thrombosis and Thrombolysis|November 2, 2007
Determining the efficacy of antiplatelet therapies for the individual: lessons from clinical trialsSteven R Steinhubl, David J Schneider, Peter B Berger, et al.
Pharmacotherapy|February 26, 2008
Clopidogrel-associated bleeding and related complications in patients undergoing coronary artery bypass graftingA Simon Pickard, Richard C Becker, Glen T Schumock, et al.
Nucleic Acid Therapeutics|February 17, 2016
Translation and Clinical Development of Antithrombotic AptamersShahid M Nimjee, Thomas J Povsic, Bruce A Sullenger, et al.
Pageof 33